Abstract
Poorly water-soluble drugs like atorvastatin with low bioavailability needs novel approach for enhancement of bioavailability and therapeutic efficacy. The use of nanotechnology to formulate as nanoemulsions offer an opportunity to address the issues associated with BCS class II drugs. Nanoemulsion of atorvastatin was developed by spontaneous emulsification method with the aim of enhancing the solubility and oral bioavailability of atorvastatin. Pseudo ternary phase diagrams were constructed to identify the nanoemulsion region. The desired formulations of nanoemulsion region were developed and characterized by globule size, scanning electron microscopy, partition coefficient, clarity, viscosity, percent drug entrapment efficiency, in vitro drug release and in vivo pharmacodynamic studies. The release of drug from nanoemulsion had significantly higher (p ‹ 0.01) as compared to the pure drug. The optimized formulation code NE3 containing 5% Oleic acid, 20% [Cremophore EL: ethanol (1:1)], and 75% of aqueous phase had enhanced solubility from 41.8 ± 2.45 to 69.07 ± 1.41. Globule size and zeta potential of the optimized nanoemulsion formulation were found to be 153.9 ± 1.02 nm and – 32.9 mV, respectively. Biopharmaceutical evaluation of the optimized nanoemulsion formulation was performed by a triton–induced hypercholesterolemia model in male albino wistar rats. The optimized nanoemulsion showed significantly reduced serum lipid levels as compared to pure atorvastatin. In conclusion, the developed nanoemulsion could be an alternative for the enhancement of solubility and bioavailability for the oral drug delivery in management of atherosclerosis.
Keywords: Atorvastatin, in vivo pharmacodynamic studies, nanoemulsion, polydispersity index, pseudo ternary phase diagram, solubility enhancement, titration method, zeta potential.
Current Nanoscience
Title:Atorvastatin-Loaded Oleic Acid Nanoglobules for Oral Administration: In Vitro Characterization and Biopharmaceutical Evaluation
Volume: 9 Issue: 2
Author(s): Pradum Pundlikrao Ige, Nilesh Ashok Bachhav, Hitendra Shaligram Mahajan, Pankaj Padmakar Nerkar and Surendra Ganeshlal Gattani
Affiliation:
Keywords: Atorvastatin, in vivo pharmacodynamic studies, nanoemulsion, polydispersity index, pseudo ternary phase diagram, solubility enhancement, titration method, zeta potential.
Abstract: Poorly water-soluble drugs like atorvastatin with low bioavailability needs novel approach for enhancement of bioavailability and therapeutic efficacy. The use of nanotechnology to formulate as nanoemulsions offer an opportunity to address the issues associated with BCS class II drugs. Nanoemulsion of atorvastatin was developed by spontaneous emulsification method with the aim of enhancing the solubility and oral bioavailability of atorvastatin. Pseudo ternary phase diagrams were constructed to identify the nanoemulsion region. The desired formulations of nanoemulsion region were developed and characterized by globule size, scanning electron microscopy, partition coefficient, clarity, viscosity, percent drug entrapment efficiency, in vitro drug release and in vivo pharmacodynamic studies. The release of drug from nanoemulsion had significantly higher (p ‹ 0.01) as compared to the pure drug. The optimized formulation code NE3 containing 5% Oleic acid, 20% [Cremophore EL: ethanol (1:1)], and 75% of aqueous phase had enhanced solubility from 41.8 ± 2.45 to 69.07 ± 1.41. Globule size and zeta potential of the optimized nanoemulsion formulation were found to be 153.9 ± 1.02 nm and – 32.9 mV, respectively. Biopharmaceutical evaluation of the optimized nanoemulsion formulation was performed by a triton–induced hypercholesterolemia model in male albino wistar rats. The optimized nanoemulsion showed significantly reduced serum lipid levels as compared to pure atorvastatin. In conclusion, the developed nanoemulsion could be an alternative for the enhancement of solubility and bioavailability for the oral drug delivery in management of atherosclerosis.
Export Options
About this article
Cite this article as:
Ige Pradum Pundlikrao, Bachhav Nilesh Ashok, Mahajan Hitendra Shaligram, Nerkar Pankaj Padmakar and Gattani Surendra Ganeshlal, Atorvastatin-Loaded Oleic Acid Nanoglobules for Oral Administration: In Vitro Characterization and Biopharmaceutical Evaluation, Current Nanoscience 2013; 9 (2) . https://dx.doi.org/10.2174/1573413711309020007
DOI https://dx.doi.org/10.2174/1573413711309020007 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammatory Markers in Coronary Artery Disease: Pathophysiological Mechanisms, Prognostic and Therapeutic Implications
Current Cardiology Reviews Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression
Current Medicinal Chemistry A Validation and Estimation of Total Eicosapentaenoic and Docosahexaenoic acids Using LC-MS/MS with Rapid Hydrolysis Enzymatic Method for Hydrolysis of Omega Lipids in Human Plasma and its Application in the Pharmacokinetic Study
Current Pharmaceutical Analysis Recent Developments in Nanoparticle Based Targeted Delivery of Chemotherapeutics
Current Bioactive Compounds Insulin Resistance, Inflammation and Atherosclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Matrix Metalloproteinases in Essential Hypertension
Current Topics in Medicinal Chemistry Artemisia Species as Potential Weapon Against Agents and Agricultural Pests
Current Biotechnology Effects of Simvastatin on the Metabolism of Fatty Acids in Combined Secondary Prevention of Coronary Heart Disease: Dosage and Gender Differences between the Effects
Cardiovascular & Hematological Disorders-Drug Targets Variability in Individual Responsiveness to Aspirin: Clinical Implications and Treatment
Cardiovascular & Hematological Disorders-Drug Targets CNS Drug Delivery Systems: Novel Approaches
Recent Patents on Drug Delivery & Formulation Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD
Current Pharmaceutical Design The Entirely Subcutaneous Defibrillator (S-Icd): State of the Art and Selection of the Ideal Candidate
Current Cardiology Reviews Towards an Experimental and Systems Biology Framework for Cancer Cell Therapeutics
Current Bioinformatics Nutraceuticals for Metabolic Syndrome Management: From Laboratory to Benchside
Current Vascular Pharmacology Implications of Angiotensin II in Central Nervous System on Exercise Performance
Current Protein & Peptide Science Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Vitamin D and Infectious Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Omega-3 Polyunsaturated Fatty Acids Supplementation in Childhood: A Review
Recent Patents on Cardiovascular Drug Discovery Vascular Effects of Phytoestrogens and Alternative Menopausal Hormone Therapy in Cardiovascular Disease
Mini-Reviews in Medicinal Chemistry Heart Failure and Diabetes: Perspective of a Dangerous Association
Current Hypertension Reviews